Orlando Daytona Beach Melbourne, FL, August 12, 2026 —

The Centers for Medicare & Medicaid Services (CMS), during the Trump administration, has announced a policy change that will end coverage for gender-affirming surgeries and hormone treatments for transgender minors. The decision impacts beneficiaries of the Medicaid program.

The precise effective date and the full scope of the policy change were not immediately detailed. However, the announcement signifies a shift in the federal program’s approach to covering such treatments for individuals under 18 years of age.

Gender-affirming care is a term that encompasses a range of services that help a person transition to their identified gender. This can include medical, psychological, and social support. For transgender minors, this care can include hormone therapy and, in some cases, surgical interventions, although surgeries are less common for this age group.

The Trump administration’s stance on LGBTQ+ rights has been a subject of scrutiny throughout its term. This policy change regarding Medicaid coverage for transgender minors is expected to face significant attention and potential challenges.

Medicaid is a federal and state program that provides health coverage to millions of Americans, including children, families, pregnant women, elderly adults, and individuals with disabilities. Coverage policies can vary between states, but federal guidelines often set a baseline.

The details regarding the implementation of this new policy, including any specific criteria or exceptions, have not been fully disclosed. Further information is anticipated regarding how this will affect current patients and future applications for such treatments through Medicaid.



Story summarized from the original created by Stephanie.Weaver@fox.com (Stephanie Weaver) on www.fox35orlando.com, see more information here.

About The Author